Information for Referring Providers
Clinical Interests for Referring Providers
Severe, early-onset fetal growth restriction
Research Interest for Referring Providers
(1) Severe, early-onset fetal growth restriction: Our lab focuses on molecular and cellular mechanisms underlying placental insufficiency-mediated fetal growth restriction, and more specifically, the molecular mechanisms that underlie abnormal fetoplacental hemodynamics (e.g. absent/reversed umbilical artery Doppler velocimetry).
(2) Chronic Hypertension and Pregnancy (CHAP) Maternal Follow-up: I am the site PI for a multi-center, NIH-funded study that investigated the role of anti-hypertensive therapy in pregnancy for mild-to-moderate chronic hypertension. This trial was completed and was published in the New England Journal of Medicine in 2022, and this study is now focused on maternal follow-up outcomes.
(3) Maternal-Fetal Medicine Units Network (MFMU): Sub-site to the Utah Clinical Center. I am the sub-site PI of this multi-center, NICHD-sponsored trial. Our institution is currently participating in SLEEP and PROSPECT.
Fax Phone: (720) 848-1844 (Referring Providers)